Illumina HiSeq 2000 sequencing; Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period

ERX1224940 E-MTAB-4027:SCV 11 E-MTAB-4027:SCV 11 Illumina HiSeq 2000 sequencing; Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERP013310 E-MTAB-4027 Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERS985274 SAMEA3678125 E-MTAB-4027:SCV 11 SCV 11 RNA-Seq TRANSCRIPTOMIC RANDOM 1x Sulfolobus medium supplemented with 0.2% sucrose, 0.2% vitamin-free casamino acids (Difco Vitamin Assay, BD), vitamin solution (Zillig et al., 1993), 0.02 mg/ml uracil TRIzol extraction, isopropanol precipitation containing 15ul glycogen (GlycoBlue), DNaseI treatment (Ambion) Total RNA library, stranded, rRNA depleted Illumina HiSeq 2000 Experimental Factor: Sulfolobus+SCVU medium growth condition Experimental Factor: STSV2 infect Experimental Factor: 242 time ERX1224941 E-MTAB-4027:SCV 11 (paired) E-MTAB-4027:SCV 11 (paired) Illumina MiSeq paired end sequencing; Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERP013310 E-MTAB-4027 Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERS985275 SAMEA3678126 E-MTAB-4027:SCV 11 (paired) SCV 11 (paired) RNA-Seq TRANSCRIPTOMIC RANDOM 1x Sulfolobus medium supplemented with 0.2% sucrose, 0.2% vitamin-free casamino acids (Difco Vitamin Assay, BD), vitamin solution (Zillig et al., 1993), 0.02 mg/ml uracil TRIzol extraction, isopropanol precipitation containing 15ul glycogen (GlycoBlue), DNaseI treatment (Ambion) Total RNA library, stranded, rRNA depleted 70 0 F Application Read Forward 1 1 R Application Read Reverse 36 Illumina MiSeq Experimental Factor: Sulfolobus+SCVU medium growth condition Experimental Factor: STSV2 infect Experimental Factor: 242 time ERX1224942 E-MTAB-4027:SCV 16 E-MTAB-4027:SCV 16 Illumina HiSeq 2000 sequencing; Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERP013310 E-MTAB-4027 Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERS985276 SAMEA3678127 E-MTAB-4027:SCV 16 SCV 16 RNA-Seq TRANSCRIPTOMIC RANDOM 1x Sulfolobus medium supplemented with 0.2% sucrose, 0.2% vitamin-free casamino acids (Difco Vitamin Assay, BD), vitamin solution (Zillig et al., 1993), 0.02 mg/ml uracil TRIzol extraction, isopropanol precipitation containing 15ul glycogen (GlycoBlue), DNaseI treatment (Ambion) Total RNA library, stranded, rRNA depleted Illumina HiSeq 2000 Experimental Factor: Sulfolobus+SCVU medium growth condition Experimental Factor: STSV2 infect Experimental Factor: 282 time ERX1224943 E-MTAB-4027:SCV 16 (paired) E-MTAB-4027:SCV 16 (paired) Illumina MiSeq paired end sequencing; Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERP013310 E-MTAB-4027 Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERS985277 SAMEA3678128 E-MTAB-4027:SCV 16 (paired) SCV 16 (paired) RNA-Seq TRANSCRIPTOMIC RANDOM 1x Sulfolobus medium supplemented with 0.2% sucrose, 0.2% vitamin-free casamino acids (Difco Vitamin Assay, BD), vitamin solution (Zillig et al., 1993), 0.02 mg/ml uracil TRIzol extraction, isopropanol precipitation containing 15ul glycogen (GlycoBlue), DNaseI treatment (Ambion) Total RNA library, stranded, rRNA depleted 70 0 F Application Read Forward 1 1 R Application Read Reverse 36 Illumina MiSeq Experimental Factor: Sulfolobus+SCVU medium growth condition Experimental Factor: STSV2 infect Experimental Factor: 282 time ERX1224944 E-MTAB-4027:SCV 2 E-MTAB-4027:SCV 2 Illumina HiSeq 2000 sequencing; Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERP013310 E-MTAB-4027 Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERS985278 SAMEA3678129 E-MTAB-4027:SCV 2 SCV 2 RNA-Seq TRANSCRIPTOMIC RANDOM 1x Sulfolobus medium supplemented with 0.2% sucrose, 0.2% vitamin-free casamino acids (Difco Vitamin Assay, BD), vitamin solution (Zillig et al., 1993), 0.02 mg/ml uracil TRIzol extraction, isopropanol precipitation containing 15ul glycogen (GlycoBlue), DNaseI treatment (Ambion) Total RNA library, stranded, rRNA depleted Illumina HiSeq 2000 Experimental Factor: Sulfolobus+SCVU medium growth condition Experimental Factor: STSV2 infect Experimental Factor: 164 time ERX1224945 E-MTAB-4027:SCV 2 (paired) E-MTAB-4027:SCV 2 (paired) Illumina MiSeq paired end sequencing; Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERP013310 E-MTAB-4027 Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERS985279 SAMEA3678130 E-MTAB-4027:SCV 2 (paired) SCV 2 (paired) RNA-Seq TRANSCRIPTOMIC RANDOM 1x Sulfolobus medium supplemented with 0.2% sucrose, 0.2% vitamin-free casamino acids (Difco Vitamin Assay, BD), vitamin solution (Zillig et al., 1993), 0.02 mg/ml uracil TRIzol extraction, isopropanol precipitation containing 15ul glycogen (GlycoBlue), DNaseI treatment (Ambion) Total RNA library, stranded, rRNA depleted 70 0 F Application Read Forward 1 1 R Application Read Reverse 36 Illumina MiSeq Experimental Factor: Sulfolobus+SCVU medium growth condition Experimental Factor: STSV2 infect Experimental Factor: 164 time ERX1224946 E-MTAB-4027:SCV 7 E-MTAB-4027:SCV 7 Illumina HiSeq 2000 sequencing; Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERP013310 E-MTAB-4027 Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERS985280 SAMEA3678131 E-MTAB-4027:SCV 7 SCV 7 RNA-Seq TRANSCRIPTOMIC RANDOM 1x Sulfolobus medium supplemented with 0.2% sucrose, 0.2% vitamin-free casamino acids (Difco Vitamin Assay, BD), vitamin solution (Zillig et al., 1993), 0.02 mg/ml uracil TRIzol extraction, isopropanol precipitation containing 15ul glycogen (GlycoBlue), DNaseI treatment (Ambion) Total RNA library, stranded, rRNA depleted Illumina HiSeq 2000 Experimental Factor: Sulfolobus+SCVU medium growth condition Experimental Factor: STSV2 infect Experimental Factor: 209 time ERX1224947 E-MTAB-4027:SCV 7 (paired) E-MTAB-4027:SCV 7 (paired) Illumina MiSeq paired end sequencing; Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERP013310 E-MTAB-4027 Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERS985281 SAMEA3678132 E-MTAB-4027:SCV 7 (paired) SCV 7 (paired) RNA-Seq TRANSCRIPTOMIC RANDOM 1x Sulfolobus medium supplemented with 0.2% sucrose, 0.2% vitamin-free casamino acids (Difco Vitamin Assay, BD), vitamin solution (Zillig et al., 1993), 0.02 mg/ml uracil TRIzol extraction, isopropanol precipitation containing 15ul glycogen (GlycoBlue), DNaseI treatment (Ambion) Total RNA library, stranded, rRNA depleted 70 0 F Application Read Forward 1 1 R Application Read Reverse 36 Illumina MiSeq Experimental Factor: Sulfolobus+SCVU medium growth condition Experimental Factor: STSV2 infect Experimental Factor: 209 time ERX1224948 E-MTAB-4027:SCV Control E-MTAB-4027:SCV Control Illumina HiSeq 2000 sequencing; Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERP013310 E-MTAB-4027 Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERS985282 SAMEA3678133 E-MTAB-4027:SCV Control SCV Control RNA-Seq TRANSCRIPTOMIC RANDOM 1x Sulfolobus medium supplemented with 0.2% sucrose, 0.2% vitamin-free casamino acids (Difco Vitamin Assay, BD), vitamin solution (Zillig et al., 1993), 0.02 mg/ml uracil TRIzol extraction, isopropanol precipitation containing 15ul glycogen (GlycoBlue), DNaseI treatment (Ambion) Total RNA library, stranded, rRNA depleted Illumina HiSeq 2000 Experimental Factor: Sulfolobus+SCVU medium growth condition Experimental Factor: uninfected infect ERX1224949 E-MTAB-4027:SCV Control (paired) E-MTAB-4027:SCV Control (paired) Illumina MiSeq paired end sequencing; Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERP013310 E-MTAB-4027 Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERS985283 SAMEA3678134 E-MTAB-4027:SCV Control (paired) SCV Control (paired) RNA-Seq TRANSCRIPTOMIC RANDOM 1x Sulfolobus medium supplemented with 0.2% sucrose, 0.2% vitamin-free casamino acids (Difco Vitamin Assay, BD), vitamin solution (Zillig et al., 1993), 0.02 mg/ml uracil TRIzol extraction, isopropanol precipitation containing 15ul glycogen (GlycoBlue), DNaseI treatment (Ambion) Total RNA library, stranded, rRNA depleted 70 0 F Application Read Forward 1 1 R Application Read Reverse 36 Illumina MiSeq Experimental Factor: Sulfolobus+SCVU medium growth condition Experimental Factor: uninfected infect ERX1224950 E-MTAB-4027:TYS 12 E-MTAB-4027:TYS 12 Illumina HiSeq 2000 sequencing; Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERP013310 E-MTAB-4027 Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERS985284 SAMEA3678135 E-MTAB-4027:TYS 12 TYS 12 RNA-Seq TRANSCRIPTOMIC RANDOM 1x Sulfolobus medium supplemented with 0.2% trypton, 0.1% yeast extract, 0.2% sucrose, 0.02 mg/ml uracil TRIzol extraction, isopropanol precipitation containing 15ul glycogen (GlycoBlue), DNaseI treatment (Ambion) Total RNA library, stranded, rRNA depleted Illumina HiSeq 2000 Experimental Factor: Sulfolobus+TYSU medium growth condition Experimental Factor: STSV2 infect Experimental Factor: 250 time ERX1224951 E-MTAB-4027:TYS 12 (paired) E-MTAB-4027:TYS 12 (paired) Illumina MiSeq paired end sequencing; Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERP013310 E-MTAB-4027 Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERS985285 SAMEA3678136 E-MTAB-4027:TYS 12 (paired) TYS 12 (paired) RNA-Seq TRANSCRIPTOMIC RANDOM 1x Sulfolobus medium supplemented with 0.2% trypton, 0.1% yeast extract, 0.2% sucrose, 0.02 mg/ml uracil TRIzol extraction, isopropanol precipitation containing 15ul glycogen (GlycoBlue), DNaseI treatment (Ambion) Total RNA library, stranded, rRNA depleted 70 0 F Application Read Forward 1 1 R Application Read Reverse 36 Illumina MiSeq Experimental Factor: Sulfolobus+TYSU medium growth condition Experimental Factor: STSV2 infect Experimental Factor: 250 time ERX1224952 E-MTAB-4027:TYS 15 E-MTAB-4027:TYS 15 Illumina HiSeq 2000 sequencing; Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERP013310 E-MTAB-4027 Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERS985286 SAMEA3678137 E-MTAB-4027:TYS 15 TYS 15 RNA-Seq TRANSCRIPTOMIC RANDOM 1x Sulfolobus medium supplemented with 0.2% trypton, 0.1% yeast extract, 0.2% sucrose, 0.02 mg/ml uracil TRIzol extraction, isopropanol precipitation containing 15ul glycogen (GlycoBlue), DNaseI treatment (Ambion) Total RNA library, stranded, rRNA depleted Illumina HiSeq 2000 Experimental Factor: Sulfolobus+TYSU medium growth condition Experimental Factor: STSV2 infect Experimental Factor: 274 time ERX1224953 E-MTAB-4027:TYS 15 (paired) E-MTAB-4027:TYS 15 (paired) Illumina MiSeq paired end sequencing; Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERP013310 E-MTAB-4027 Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERS985287 SAMEA3678138 E-MTAB-4027:TYS 15 (paired) TYS 15 (paired) RNA-Seq TRANSCRIPTOMIC RANDOM 1x Sulfolobus medium supplemented with 0.2% trypton, 0.1% yeast extract, 0.2% sucrose, 0.02 mg/ml uracil TRIzol extraction, isopropanol precipitation containing 15ul glycogen (GlycoBlue), DNaseI treatment (Ambion) Total RNA library, stranded, rRNA depleted 70 0 F Application Read Forward 1 1 R Application Read Reverse 36 Illumina MiSeq Experimental Factor: Sulfolobus+TYSU medium growth condition Experimental Factor: STSV2 infect Experimental Factor: 274 time ERX1224954 E-MTAB-4027:TYS 2 E-MTAB-4027:TYS 2 Illumina HiSeq 2000 sequencing; Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERP013310 E-MTAB-4027 Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERS985288 SAMEA3678139 E-MTAB-4027:TYS 2 TYS 2 RNA-Seq TRANSCRIPTOMIC RANDOM 1x Sulfolobus medium supplemented with 0.2% trypton, 0.1% yeast extract, 0.2% sucrose, 0.02 mg/ml uracil TRIzol extraction, isopropanol precipitation containing 15ul glycogen (GlycoBlue), DNaseI treatment (Ambion) Total RNA library, stranded, rRNA depleted Illumina HiSeq 2000 Experimental Factor: Sulfolobus+TYSU medium growth condition Experimental Factor: STSV2 infect Experimental Factor: 164 time ERX1224955 E-MTAB-4027:TYS 2 (paired) E-MTAB-4027:TYS 2 (paired) Illumina MiSeq paired end sequencing; Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERP013310 E-MTAB-4027 Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERS985289 SAMEA3678140 E-MTAB-4027:TYS 2 (paired) TYS 2 (paired) RNA-Seq TRANSCRIPTOMIC RANDOM 1x Sulfolobus medium supplemented with 0.2% trypton, 0.1% yeast extract, 0.2% sucrose, 0.02 mg/ml uracil TRIzol extraction, isopropanol precipitation containing 15ul glycogen (GlycoBlue), DNaseI treatment (Ambion) Total RNA library, stranded, rRNA depleted 70 0 F Application Read Forward 1 1 R Application Read Reverse 36 Illumina MiSeq Experimental Factor: Sulfolobus+TYSU medium growth condition Experimental Factor: STSV2 infect Experimental Factor: 164 time ERX1224956 E-MTAB-4027:TYS 6 E-MTAB-4027:TYS 6 Illumina HiSeq 2000 sequencing; Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERP013310 E-MTAB-4027 Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERS985290 SAMEA3678141 E-MTAB-4027:TYS 6 TYS 6 RNA-Seq TRANSCRIPTOMIC RANDOM 1x Sulfolobus medium supplemented with 0.2% trypton, 0.1% yeast extract, 0.2% sucrose, 0.02 mg/ml uracil TRIzol extraction, isopropanol precipitation containing 15ul glycogen (GlycoBlue), DNaseI treatment (Ambion) Total RNA library, stranded, rRNA depleted Illumina HiSeq 2000 Experimental Factor: Sulfolobus+TYSU medium growth condition Experimental Factor: STSV2 infect Experimental Factor: 202 time ERX1224957 E-MTAB-4027:TYS 6 (paired) E-MTAB-4027:TYS 6 (paired) Illumina MiSeq paired end sequencing; Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERP013310 E-MTAB-4027 Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERS985291 SAMEA3678142 E-MTAB-4027:TYS 6 (paired) TYS 6 (paired) RNA-Seq TRANSCRIPTOMIC RANDOM 1x Sulfolobus medium supplemented with 0.2% trypton, 0.1% yeast extract, 0.2% sucrose, 0.02 mg/ml uracil TRIzol extraction, isopropanol precipitation containing 15ul glycogen (GlycoBlue), DNaseI treatment (Ambion) Total RNA library, stranded, rRNA depleted 70 0 F Application Read Forward 1 1 R Application Read Reverse 36 Illumina MiSeq Experimental Factor: Sulfolobus+TYSU medium growth condition Experimental Factor: STSV2 infect Experimental Factor: 202 time ERX1224958 E-MTAB-4027:TYS Control E-MTAB-4027:TYS Control Illumina HiSeq 2000 sequencing; Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERP013310 E-MTAB-4027 Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERS985292 SAMEA3678143 E-MTAB-4027:TYS Control TYS Control RNA-Seq TRANSCRIPTOMIC RANDOM 1x Sulfolobus medium supplemented with 0.2% trypton, 0.1% yeast extract, 0.2% sucrose, 0.02 mg/ml uracil TRIzol extraction, isopropanol precipitation containing 15ul glycogen (GlycoBlue), DNaseI treatment (Ambion) Total RNA library, stranded, rRNA depleted Illumina HiSeq 2000 Experimental Factor: Sulfolobus+TYSU medium growth condition Experimental Factor: uninfected infect ERX1224959 E-MTAB-4027:TYS Control (paired) E-MTAB-4027:TYS Control (paired) Illumina MiSeq paired end sequencing; Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERP013310 E-MTAB-4027 Continuous CRISPR spacer acquisition in STSV2-infected crenarchaeon Sulfolobus islandicus REY15A over a 6-day period ERS985293 SAMEA3678144 E-MTAB-4027:TYS Control (paired) TYS Control (paired) RNA-Seq TRANSCRIPTOMIC RANDOM 1x Sulfolobus medium supplemented with 0.2% trypton, 0.1% yeast extract, 0.2% sucrose, 0.02 mg/ml uracil TRIzol extraction, isopropanol precipitation containing 15ul glycogen (GlycoBlue), DNaseI treatment (Ambion) Total RNA library, stranded, rRNA depleted 70 0 F Application Read Forward 1 1 R Application Read Reverse 36 Illumina MiSeq Experimental Factor: Sulfolobus+TYSU medium growth condition Experimental Factor: uninfected infect